Subscribe
Subscribe
Subscribe Options (Close)
Topic: life sciences
New with Topic: life sciences
Abhishek Tiwari posted a tweet
The ten most exciting tools to hit the life sciences this year http://tinyurl.com/ycqwdcs
hansonexperience posted a blog entry
Videoblog: uitreiking prijs "Meest innovatieve instelling 2009" aan de HAN
Vanmiddag kreeg de HAN en dan met name de Faculteit Techniek uit handen van Jeroen van der Veer, voorzitter van het Platform...
Vanmiddag kreeg de HAN en dan met name de Faculteit Techniek uit handen van Jeroen van der Veer, voorzitter van het Platform...
hansonexperience posted new photos
10 hours ago
Flickr
| Topics: han, lifesciences, techniek, hogeschool... | Add flickr to your profile
Flickr
| Topics: han, lifesciences, techniek, hogeschool... | Add flickr to your profileLowongan Kerja posted a blog entry
Clinical Trial Leader – Contract
Our client, is seeking a Clinical Trial Leader for their offices based in Switzerland on a contract role.JOB ROLE: ...
Our client, is seeking a Clinical Trial Leader for their offices based in Switzerland on a contract role.JOB ROLE: ...
Xconomy posted a blog entry
Forma Gets a $25.5M Fix, Novartis Bids Idera Adieu, Alnylam CEO Talks Strategy, & More Boston-Area Life Sciences News
Somewhere between the turkey prep and the post-pie catatonia, folks at New England’s life sciences companies managed to...
Somewhere between the turkey prep and the post-pie catatonia, folks at New England’s life sciences companies managed to...
21 hours ago
Xconomy - Business + Technology in the Exponential Economy
| Topics: Boston, Boston blog..., National blog..., Roundup
Xconomy - Business + Technology in the Exponential Economy
| Topics: Boston, Boston blog..., National blog..., RoundupXconomy posted a blog entry
Quick Take: Novartis Vaccine Chief Andrin Oswald on Swine Flu and Vaccine Business
It’s been a year since Andrin Oswald took over as CEO of Novartis Vaccines and Diagnostics, the 5th-largest vaccine...
It’s been a year since Andrin Oswald took over as CEO of Novartis Vaccines and Diagnostics, the 5th-largest vaccine...
24 hours ago
Xconomy - Business + Technology in the Exponential Economy
| Topics: Boston, Boston blog..., National blog..., Life Sciences
Xconomy - Business + Technology in the Exponential Economy
| Topics: Boston, Boston blog..., National blog..., Life SciencesXconomy posted a blog entry
Dyax Shares Rocket as FDA Clears Treatment for Rare Inflammatory Disease
Dyax got some good news late today that sent shares booming. The Cambridge, MA-based company (NASDAQ: DYAX) said it has...
Dyax got some good news late today that sent shares booming. The Cambridge, MA-based company (NASDAQ: DYAX) said it has...
1 day ago
Xconomy - Business + Technology in the Exponential Economy
| Topics: Boston, Boston blog..., National blog..., Biotech
Xconomy - Business + Technology in the Exponential Economy
| Topics: Boston, Boston blog..., National blog..., BiotechXconomy posted a blog entry
Santarus Shares Boom on FDA Approval of Over-the-Counter Heartburn Drug
San Diego-based Santarus (NASDAQ: SNTS) got some good news late today. The company’s partner, the Schering-Plough unit of...
San Diego-based Santarus (NASDAQ: SNTS) got some good news late today. The company’s partner, the Schering-Plough unit of...
1 day ago
Xconomy - Business + Technology in the Exponential Economy
| Topics: National blog..., San Diego, San Diego blog..., Biotech
Xconomy - Business + Technology in the Exponential Economy
| Topics: National blog..., San Diego, San Diego blog..., BiotechXconomy posted a blog entry
Tech Executive Pay Raises Way Down, New Study Says
Technology executive pay raises in 2009 have taken their biggest nosedive of the past decade, according to a new compensation...
Technology executive pay raises in 2009 have taken their biggest nosedive of the past decade, according to a new compensation...
hansonexperience posted a blog entry
Videoblog: Reunie HAN HLO
Afgelopen zaterdag was de 1e reunie van HAN HLO en Veliant (de alumni vereniging). Ruim 200 belangstellenden waren aanwezig. De...
Afgelopen zaterdag was de 1e reunie van HAN HLO en Veliant (de alumni vereniging). Ruim 200 belangstellenden waren aanwezig. De...
hansonexperience posted a blog entry
Fotoblog: Reunie HAN HLO
Afgelopen zaterdag was de 1e reunie van oud-studenten van de HAN Hogere Laboratorium Opleidingen. Hieronder een foto-impressie....
Afgelopen zaterdag was de 1e reunie van oud-studenten van de HAN Hogere Laboratorium Opleidingen. Hieronder een foto-impressie....
Xconomy posted a blog entry
Ekos, Enduring Tough Year for Devices, Sticks With Goal to Break Even Next Year
Ekos is on a quest to change the way doctors think about how to best dissolve blood clots. Like a lot of bold visions, this...
Ekos is on a quest to change the way doctors think about how to best dissolve blood clots. Like a lot of bold visions, this...
3 days ago
Xconomy - Business + Technology in the Exponential Economy
| Topics: National blog..., Seattle, Seattle blog..., Biotech
Xconomy - Business + Technology in the Exponential Economy
| Topics: National blog..., Seattle, Seattle blog..., BiotechIanMcKendrick posted a tweet
A great audience tonight at rhe ERBI IT Special Interest Group seminar on Cloud Computing for life sciences. http://twitpic.com/r1zkw
Xconomy posted a blog entry
Enigma Names Top U.S. Execs
Enigma Diagnostics, the UK genetic diagnosis instrument maker that is setting up its U.S. shop in San Diego, today named Jorge...
Enigma Diagnostics, the UK genetic diagnosis instrument maker that is setting up its U.S. shop in San Diego, today named Jorge...
7 days ago
Xconomy - Business + Technology in the Exponential Economy
| Topics: National..., San Diego, San Diego..., people
Xconomy - Business + Technology in the Exponential Economy
| Topics: National..., San Diego, San Diego..., peopleXconomy posted a blog entry
Illumina OKs $100M Share Buyback
San Diego-based Illumina (NASDAQ: ILMN) said today that its board has authorized a program to buy back $100 million of stock....
San Diego-based Illumina (NASDAQ: ILMN) said today that its board has authorized a program to buy back $100 million of stock....
8 days ago
Xconomy - Business + Technology in the Exponential Economy
| Topics: National..., San Diego, San Diego..., Biotech
Xconomy - Business + Technology in the Exponential Economy
| Topics: National..., San Diego, San Diego..., BiotechKnowledge beyond words posted a tweet
RT @dullhunk: New blog post at O'Really? #swat4ls2009 Semantic Web Applications and Tools for the Life Sciences, (...) http://bit.ly/5YXwgs
Xconomy posted a blog entry
Under the Radar Deals: 10 (+1) New England October Financings You Never Heard About
The big picture is great. But at Xconomy, we also like the smaller details, which often fill in or round out the big...
The big picture is great. But at Xconomy, we also like the smaller details, which often fill in or round out the big...
10 days ago
Xconomy - Business + Technology in the Exponential Economy
| Topics: Boston, Boston blog..., National blog..., VC
Xconomy - Business + Technology in the Exponential Economy
| Topics: Boston, Boston blog..., National blog..., VCXconomy posted a blog entry
Ironwood Files to Go Public, Seeks to Raise as Much as $172.5M
Ironwood Pharmaceuticals is gearing up for the possibility of an IPO. The Cambridge, MA-based developer of a new treatment for...
Ironwood Pharmaceuticals is gearing up for the possibility of an IPO. The Cambridge, MA-based developer of a new treatment for...
12 days ago
Xconomy - Business + Technology in the Exponential Economy
| Topics: Boston, Boston blog..., National blog..., Biotech
Xconomy - Business + Technology in the Exponential Economy
| Topics: Boston, Boston blog..., National blog..., BiotechXconomy posted a blog entry
Blue Marble Snags $2M State Grant
Seattle-based Blue Marble Energy, the developer of renewable energy and specialty chemicals from biomass, said it has received...
Seattle-based Blue Marble Energy, the developer of renewable energy and specialty chemicals from biomass, said it has received...
12 days ago
Xconomy - Business + Technology in the Exponential Economy
| Topics: National..., Seattle, Seattle..., cleantech
Xconomy - Business + Technology in the Exponential Economy
| Topics: National..., Seattle, Seattle..., cleantechXconomy posted a blog entry
Biogen Idec Accused Again of Excessive CEO Pay, Lousy Performance, By Big Shareholder
[Update: 1:55 pm Eastern, 11/20/09] After a bitter standoff earlier this year with billionaire investor Carl Icahn over alleged...
[Update: 1:55 pm Eastern, 11/20/09] After a bitter standoff earlier this year with billionaire investor Carl Icahn over alleged...
12 days ago
Xconomy - Business + Technology in the Exponential Economy
| Topics: Boston, Boston blog..., National blog..., San Diego blog...
Xconomy - Business + Technology in the Exponential Economy
| Topics: Boston, Boston blog..., National blog..., San Diego blog...Xconomy posted a blog entry
$31.3M for Cambridgesoft
Cambridge, MA-based Cambridgesoft, which makes software for life sciences companies, disclosed in regulatory documents filed...
Cambridge, MA-based Cambridgesoft, which makes software for life sciences companies, disclosed in regulatory documents filed...
13 days ago
Xconomy - Business + Technology in the Exponential Economy
| Topics: Boston, Boston briefs, National..., IT
Xconomy - Business + Technology in the Exponential Economy
| Topics: Boston, Boston briefs, National..., ITXconomy posted a blog entry
Dendreon FDA Deadline Set For May 1
Seattle-based Dendreon (NASDAQ: DNDN), the developer of what it hopes will be the first FDA-approved treatment to actively...
Seattle-based Dendreon (NASDAQ: DNDN), the developer of what it hopes will be the first FDA-approved treatment to actively...
13 days ago
Xconomy - Business + Technology in the Exponential Economy
| Topics: National..., Seattle, Seattle..., Biotech
Xconomy - Business + Technology in the Exponential Economy
| Topics: National..., Seattle, Seattle..., Biotechemac posted a tweet
RBC Life Sciences Announces Third Quarter 2009 Results http://bit.ly/1dY8hw
Xconomy posted a blog entry
Beyond Anecdotes: Measuring Global Health Impact in Washington State
The threat of global infectious disease was already a significant humanitarian concern when Ken Stuart set up his independent...
The threat of global infectious disease was already a significant humanitarian concern when Ken Stuart set up his independent...
14 days ago
Xconomy - Business + Technology in the Exponential Economy
| Topics: National Xcon, Seattle, Seattle Xcon, Biotech
Xconomy - Business + Technology in the Exponential Economy
| Topics: National Xcon, Seattle, Seattle Xcon, BiotechXconomy posted a blog entry
Genzyme Halts Development of New Kidney Drug; A “Very Significant” Bust, Analyst Says
Another day, another piece of bad news from Genzyme. The Cambridge, MA-based biotech giant (NASDAQ: GENZ) said today it is...
Another day, another piece of bad news from Genzyme. The Cambridge, MA-based biotech giant (NASDAQ: GENZ) said today it is...
15 days ago
Xconomy - Business + Technology in the Exponential Economy
| Topics: Boston, Boston blog..., National blog..., Biotech
Xconomy - Business + Technology in the Exponential Economy
| Topics: Boston, Boston blog..., National blog..., BiotechXconomy posted a blog entry
Trubion CEO Peter Thompson Steps Down, Arch’s Gillis To Step Up Temporarily
[Updated: 5:55 pm Pacific, 11/16/09] Trubion Pharmaceuticals, the Seattle-based company developing new drugs for autoimmune...
[Updated: 5:55 pm Pacific, 11/16/09] Trubion Pharmaceuticals, the Seattle-based company developing new drugs for autoimmune...
16 days ago
Xconomy - Business + Technology in the Exponential Economy
| Topics: National blog..., Seattle, Seattle blog..., Biotech
Xconomy - Business + Technology in the Exponential Economy
| Topics: National blog..., Seattle, Seattle blog..., BiotechXconomy posted a blog entry
Fate Therapeutics Bags $30M Venture Deal, Led by OVP, to Develop “Industrialized” Stem Cells
Fate Therapeutics, the San Diego-based company on a quest to develop techniques that make stem cell research practical for the...
Fate Therapeutics, the San Diego-based company on a quest to develop techniques that make stem cell research practical for the...
17 days ago
Xconomy - Business + Technology in the Exponential Economy
| Topics: Boston blog..., National, National blog..., San Diego blog...
Xconomy - Business + Technology in the Exponential Economy
| Topics: Boston blog..., National, National blog..., San Diego blog...Xconomy posted a blog entry
Cadence Hit By FDA Delay
San Diego-based Cadence Pharmaceuticals (NASDAQ: CADX) said today that the FDA has pushed back its deadline for reviewing the...
San Diego-based Cadence Pharmaceuticals (NASDAQ: CADX) said today that the FDA has pushed back its deadline for reviewing the...
19 days ago
Xconomy - Business + Technology in the Exponential Economy
| Topics: National..., San Diego, San Diego..., Biotech
Xconomy - Business + Technology in the Exponential Economy
| Topics: National..., San Diego, San Diego..., BiotechXconomy posted a blog entry
Trius Therapeutics Reveals Plans for IPO, SpectraScience Raises $4.3M, Sequenom Tightens its Belt, & More San Diego Life Sciences News
Some San Diego life sciences companies reported a burst of new financing, while embattled Sequenom told investors it’s trying...
Some San Diego life sciences companies reported a burst of new financing, while embattled Sequenom told investors it’s trying...
21 days ago
Xconomy - Business + Technology in the Exponential Economy
| Topics: National blog..., San Diego, San Diego blog..., Roundup
Xconomy - Business + Technology in the Exponential Economy
| Topics: National blog..., San Diego, San Diego blog..., RoundupXconomy posted a blog entry
Alder’s Breakout $1B Deal, Kineta Teams With UW on Vaccines, Verathon Gets Acquired, & More Seattle-Area Life Sciences News
This was the week that a little biotech company in Bothell that few of the locals have ever heard of, burst onto the national...
This was the week that a little biotech company in Bothell that few of the locals have ever heard of, burst onto the national...
21 days ago
Xconomy - Business + Technology in the Exponential Economy
| Topics: National blog..., Seattle, Seattle blog..., Roundup
Xconomy - Business + Technology in the Exponential Economy
| Topics: National blog..., Seattle, Seattle blog..., RoundupXconomy posted a blog entry
Aileron’s New Class of Drugs Shown to Get Inside Cells to Block Prime Cancer Target
Cambridge, MA-based Aileron Therapeutics has bet the company on the idea that it has discovered a whole new class of drugs...
Cambridge, MA-based Aileron Therapeutics has bet the company on the idea that it has discovered a whole new class of drugs...
21 days ago
Xconomy - Business + Technology in the Exponential Economy
| Topics: Boston, Boston blog..., National blog..., Biotech
Xconomy - Business + Technology in the Exponential Economy
| Topics: Boston, Boston blog..., National blog..., BiotechXconomy posted a blog entry
Pulmatrix Pulls in $30.2M, GenArts Gobbles Up Wondertouch, BioVex Bags $30M, & More Boston-Area Deals News
Several of New England’s tech and life sciences firms got juicy deals the past week and a half.—Boston’s...
Several of New England’s tech and life sciences firms got juicy deals the past week and a half.—Boston’s...
22 days ago
Xconomy - Business + Technology in the Exponential Economy
| Topics: Boston, Boston blog..., National blog..., Roundup
Xconomy - Business + Technology in the Exponential Economy
| Topics: Boston, Boston blog..., National blog..., RoundupXconomy posted a blog entry
Alder and New Partner, Bristol, to Give Amgen and Abbott a Run for Their Money
Alder Biopharmaceuticals keeps such a low profile that even after five years in business, few people in Seattle biotech know...
Alder Biopharmaceuticals keeps such a low profile that even after five years in business, few people in Seattle biotech know...
22 days ago
Xconomy - Business + Technology in the Exponential Economy
| Topics: National blog..., Seattle, Seattle blog..., Biotech
Xconomy - Business + Technology in the Exponential Economy
| Topics: National blog..., Seattle, Seattle blog..., BiotechXconomy posted a blog entry
Right Brains Wanted: Sanofi-Aventis Wants to Tap the Creative Genius of Boston-Area Biotechs
Sanofi-Aventis (NYSE: SNY) hosted a large event at its R&D site in Cambridge, MA, yesterday to make its pitch for why...
Sanofi-Aventis (NYSE: SNY) hosted a large event at its R&D site in Cambridge, MA, yesterday to make its pitch for why...
22 days ago
Xconomy - Business + Technology in the Exponential Economy
| Topics: Boston, Boston blog..., National blog..., Life Sciences
Xconomy - Business + Technology in the Exponential Economy
| Topics: Boston, Boston blog..., National blog..., Life SciencesJKW posted a tweet
RT @rubp Social Media in the Life Sciences http://bit.ly/2BpLzb from @Bioinfo #socialmedia #lifescience #science
Eamonn posted a blog entry
What’s Hot (November)
Continuing from our last "What's Hot Right Now" spot, we'll continue this and hereby promise to make this a monthly section...
Continuing from our last "What's Hot Right Now" spot, we'll continue this and hereby promise to make this a monthly section...
Related topics
autotechniek
biotech
boston
Boston blog main
deals
drugs
han
hogeschool van arnhem en nijmegen
National blog main
National briefs
seattle
Seattle blog main
startups
Techniek
Top members tagged
Top communities tagged
You
Explore
Create
Help
MyBlogLog Blog | MyBlogLog RSS Feed | Terms of Service | Privacy Policy | Report Abuse
Copyright © 2005-2009 MyBlogLog. All rights reserved. Copyright/IP Policy














